Get started
RocketTickers

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sul

Long
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)  
RocketTickers  
NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
Beyond Technical Analysis
0
0
beyondta
AMPH: Amphastar Pharmaceuticals, Inc.
2021-05-03 06:00:00
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.